Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke.
Overview
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China
- Academy of Integration of Chinese and Western Medicine, Peking University Health Science Center, Beijing, China
- The Key Discipline for Integration of Chinese and Western Basic Medicine (Microcirculation) of the National Administration of Traditional Chinese Medicine, Beijing, China
- Key Laboratory of Stasis and Phlegm, State Administration of Traditional Chinese Medicine of the People’s Republic of China, Beijing, China
- Beijing Microvascular Institute of Integration of Chinese and Western Medicine, Beijing, China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper links to its data, not to its authors' code: see the Data section.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- figshare:31828060, at figshare; found in “Data availability”
- figshare:32084754, at figshare; found in “Data availability”
- figshare:32086650, at figshare; found in “Data availability”
- pride:PXD068816, at PRIDE; found in “Data availability”
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it points to 4 datasets: figshare 31828060, figshare 32084754, figshare 32086650, PRIDE PXD068816
Read it in the paper: doi.org/10.1038/s41467-026-73995-0.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 2 keywords, 14 MeSH terms, 46 references.
Cite
This paper
Guo, S., Li, A.-Q., Chen, F.-K., Weng, D.-Z., Wang, Z., Yang, C., Zhang, Y.-J., Zhang, Y., Chang, X., Liang, H.-B., & Liu, J. (2026). Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke. Nature communications, 17(1), 7250. https://
BibTeX
@article{guo2026anisodin
author = {Guo, Song and Li, An-Qing and Chen, Fan-Kai and Weng, Ding-Zhou and Wang, Zheng and Yang, Chong and Zhang, Yu-Jie and Zhang, Yi and Chang, Xin and Liang, Hong-Biao and Liu, Jian},
title = {{Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke}},
journal = {Nature communications},
year = {2026},
month = jun,
volume = {17},
number = {1},
pages = {7250},
publisher = {Nature Publishing Group},
issn = {2041-1723},
doi = {10.1038/
url = {https://
pmid = {42259802},
pmcid = {PMC13396228}
}
RIS
TY - JOUR
AU - Guo, Song
AU - Li, An-Qing
AU - Chen, Fan-Kai
AU - Weng, Ding-Zhou
AU - Wang, Zheng
AU - Yang, Chong
AU - Zhang, Yu-Jie
AU - Zhang, Yi
AU - Chang, Xin
AU - Liang, Hong-Biao
AU - Liu, Jian
TI - Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke
T2 - Nature communications
J2 - Nat Commun
PY - 2026
DA - 2026/
VL - 17
IS - 1
SP - 7250
SN - 2041-1723
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke",
"container-title": "Nature communications",
"author": [
{
"family": "Guo",
"given": "Song"
},
{
"family": "Li",
"given": "An-Qing"
},
{
"family": "Chen",
"given": "Fan-Kai"
},
{
"family": "Weng",
"given": "Ding-Zhou"
},
{
"family": "Wang",
"given": "Zheng"
},
{
"family": "Yang",
"given": "Chong"
},
{
"family": "Zhang",
"given": "Yu-Jie"
},
{
"family": "Zhang",
"given": "Yi"
},
{
"family": "Chang",
"given": "Xin"
},
{
"family": "Liang",
"given": "Hong-Biao"
},
{
"family": "Liu",
"given": "Jian"
}
],
"container-title-short":
"volume": "17",
"issue": "1",
"page": "7250",
"DOI": "10.1038/
"PMID": "42259802",
"PMCID": "PMC13396228",
"ISSN": "2041-1723",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
8
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41598-026-48239-2 [code]
- LigGen-a GEN-AI based ligand generation approach for de-novo drug design.Journal: Scientific reportsIn common: 2 references
- [2] doi:10.3390/biomedicines14050998 [code]
- Integrative Multi-Omics and Machine Learning Analysis Identifies Therapeutic Targets and Drug Repurposing Candidates for Alzheimer's Disease.Journal: BiomedicinesIn common: 2 references
- [3] doi:10.1186/s13293-026-00941-6
- Prenatal BPA exposure perturbs RNA-binding protein-mediated splicing regulation and synaptogenesis in the developing cerebellum in a sex-dependent manner.Journal: Biology of sex differencesIn common: 2 references
- [4] doi:10.1186/s12929-026-01271-w
- Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia.Journal: Journal of biomedical scienceIn common: stroke, mouse, 1 reference
- [5] doi:10.1021/acsptsci.5c00821
- Blood-Brain Barrier (BBB)-Penetrable Androgen Receptor (AR) Degrader as a Potential Therapeutic Agent for Glioblastoma.Journal: ACS pharmacology & translational scienceIn common: 2 references
- [6] doi:10.1161/jaha.125.046088 [code]
- Systematic Identification of Therapeutic Targets and Repurposed Drugs for Stroke: From Genome Causal Analysis to Multilevel Validation.Journal: Journal of the American Heart AssociationIn common: stroke, mouse, 1 reference
- [7] doi:10.1038/s41598-026-66143-7
- Recombinant CXCL16 reduces brain injury by modulating microglial phenotype and attenuating apoptosis in acute ischemic stroke.Journal: Scientific reportsIn common: stroke, mouse, 1 reference
- [8] doi:10.1016/j.neurot.2026.e00977
- Exosome-mediated delivery of 3-n-butylphthalide rescues microglial energy crisis and ameliorates neuroinflammation in ischemic stroke.Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeuticsIn common: stroke, mouse, 1 reference
- [9] doi:10.1016/j.redox.2026.104210
- Vespakinin-M delineates an AMPK/
mTOR-arginine-TCA cycle axis to act as an immunometabolic switch in post-stroke microglia. Journal: Redox biologyIn common: stroke, mouse, 1 reference - [10] doi:10.1016/j.isci.2026.115779
- Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/
NLRP3 pathway. Journal: iScienceIn common: stroke, mouse, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
